Convergence Investment Partners LLC bought a new position in shares of Imperva, Inc. (NASDAQ:IMPV) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 35,257 shares of the software maker’s stock, valued at approximately $1,530,000. Convergence Investment Partners LLC owned approximately 0.10% of Imperva as of its most recent SEC filing.

Several other large investors have also made changes to their positions in IMPV. Teachers Advisors LLC boosted its position in shares of Imperva by 2.6% during the 1st quarter. Teachers Advisors LLC now owns 48,482 shares of the software maker’s stock worth $1,990,000 after acquiring an additional 1,220 shares in the last quarter. Schwab Charles Investment Management Inc. boosted its position in shares of Imperva by 5.6% during the 1st quarter. Schwab Charles Investment Management Inc. now owns 119,475 shares of the software maker’s stock worth $4,905,000 after acquiring an additional 6,309 shares in the last quarter. State Street Corp boosted its position in shares of Imperva by 2.6% during the 1st quarter. State Street Corp now owns 532,533 shares of the software maker’s stock worth $21,859,000 after acquiring an additional 13,390 shares in the last quarter. Aperio Group LLC boosted its position in shares of Imperva by 8.1% during the 2nd quarter. Aperio Group LLC now owns 7,114 shares of the software maker’s stock worth $340,000 after acquiring an additional 531 shares in the last quarter. Finally, US Bancorp DE boosted its position in shares of Imperva by 11.7% during the 2nd quarter. US Bancorp DE now owns 6,016 shares of the software maker’s stock worth $287,000 after acquiring an additional 630 shares in the last quarter. Hedge funds and other institutional investors own 96.95% of the company’s stock.

Several analysts recently issued reports on IMPV shares. Evercore ISI set a $56.00 price target on shares of Imperva and gave the stock a “buy” rating in a research report on Thursday, August 10th. BidaskClub upgraded shares of Imperva from a “sell” rating to a “hold” rating in a research report on Tuesday, August 22nd. Piper Jaffray Companies set a $58.00 price target on shares of Imperva and gave the stock a “buy” rating in a research report on Monday, August 28th. Zacks Investment Research lowered shares of Imperva from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, September 27th. Finally, Wells Fargo & Company lowered shares of Imperva from an “outperform” rating to a “market perform” rating in a research report on Monday, October 9th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. Imperva has a consensus rating of “Hold” and an average price target of $52.38.

Imperva, Inc. (NASDAQ:IMPV) opened at $40.55 on Wednesday. Imperva, Inc. has a 52 week low of $35.80 and a 52 week high of $52.40.

Imperva (NASDAQ:IMPV) last issued its quarterly earnings data on Wednesday, November 8th. The software maker reported $0.33 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.22 by $0.11. The business had revenue of $83.89 million during the quarter, compared to the consensus estimate of $83.79 million. Imperva had a net margin of 3.04% and a negative return on equity of 8.52%. The firm’s revenue was up 22.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.08 EPS. sell-side analysts expect that Imperva, Inc. will post -0.52 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This article was first published by Watch List News and is owned by of Watch List News. If you are reading this article on another publication, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this article can be viewed at https://www.watchlistnews.com/convergence-investment-partners-llc-buys-shares-of-35257-imperva-inc-impv/1746876.html.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Want to see what other hedge funds are holding IMPV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Imperva, Inc. (NASDAQ:IMPV).

Institutional Ownership by Quarter for Imperva (NASDAQ:IMPV)

Receive News & Ratings for Imperva Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.